Cargando…

Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer

Detalles Bibliográficos
Autores principales:	Gerdts, Ethan, Priceman, Saul, Tilakawardane, Dileshni, Park, Anthony, Chang, Wen-Chung, Wright, Sarah, Brown, Christine E, Forman, Stephen J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646040/ http://dx.doi.org/10.1186/2051-1426-3-S2-P115

Ejemplares similares

Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
por: Priceman, Saul J., et al.
Publicado: (2017)

Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis
por: Priceman, Saul, et al.
Publicado: (2015)

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
por: Park, Anthony K, et al.
Publicado: (2015)

Prostate stem cell antigen (PSCA) and risk of bladder cancer: linking genotypes to functional mechanisms
por: Mumy, Adam, et al.
Publicado: (2011)

Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity
por: Murad, John P., et al.
Publicado: (2021)

Genetic variation in PSCA gene and bladder cancer susceptibility in North Indian population
por: Jaiswal, Praveen K, et al.
Publicado: (2014)

A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk
por: Fu, Yi-Ping, et al.
Publicado: (2011)

Chimeric antigen receptors (CARs) incorporating mutations in the IgG4 Fc spacer region to eliminate Fc receptor recognition results in improved CAR T cell persistence and anti-tumor efficacy
por: Jonnalagadda, Mahesh, et al.
Publicado: (2013)

Optimizing the Preparation Procedure of Recombinant PSCA, as a Practical Biomarker in Prostate Cancer
por: Shahrabi Farahani, Mahboube, et al.
Publicado: (2021)

Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
por: Brown, Christine E, et al.
Publicado: (2015)

Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
por: Brown, Christine E, et al.
Publicado: (2013)

Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells
por: Kang, Ran, et al.
Publicado: (2016)

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer
por: Xiang, Qian, et al.
Publicado: (2020)

Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
por: Feldmann, Anja, et al.
Publicado: (2017)

Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
por: Hillerdal, Victoria, et al.
Publicado: (2014)

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer
por: Lee, Il-Seok, et al.
Publicado: (2017)

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
por: Heinrich, Marie-Christine, et al.
Publicado: (2018)

PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy
por: Zhang, Xuefeng, et al.
Publicado: (2017)

Dendritic Cell-Directed Vaccination with a Lentivector Encoding PSCA for Prostate Cancer in Mice
por: Xiao, Liang, et al.
Publicado: (2012)

Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients
por: Mahmoud, Mustafa M, et al.
Publicado: (2023)

Development of chimeric antigen receptor-redirected T cell therapy targeting L1-CAM in ovarian cancer
por: Hong, Hao, et al.
Publicado: (2013)

Impact of PSCA Variation on Gastric Ulcer Susceptibility
por: Tanikawa, Chizu, et al.
Publicado: (2013)

Impact of PSCA Polymorphisms on the Risk of Duodenal Ulcer
por: Usui, Yoshiaki, et al.
Publicado: (2021)

Effective Targeting of TAG72(+) Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells
por: Murad, John P., et al.
Publicado: (2018)

Single cell metrics of the efficacy of CAR T cells
por: Romain, Gabrielle, et al.
Publicado: (2015)

An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
por: Lepin, Eric J., et al.
Publicado: (2010)

The therapeutic efficacy of I(131)-PSCA-mAb in orthotopic mouse models of prostate cancer
por: Yu, Shengqiang, et al.
Publicado: (2013)

Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody
por: Tsai, Wenting K, et al.
Publicado: (2018)

PSCA rs2294008 Polymorphism with Increased Risk of Cancer
por: Geng, Peiliang, et al.
Publicado: (2015)

Correction: Impact of PSCA Variation on Gastric Ulcer Susceptibility
Publicado: (2014)

Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion
por: Jacoby, Elad, et al.
Publicado: (2015)

Quantitative single-cell characterization of CAR+ T cell effector functions
por: Liadi, Ivan, et al.
Publicado: (2013)

Enhancing T cell persistence of CAR-redirected T cells in solid tumors
por: Guedan, Sonia, et al.
Publicado: (2014)

Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer
por: Zhigang, Zhao, et al.
Publicado: (2004)

Go-CART: an animal-free system for the assessment of CAR T cell function
por: Bajgain, Pradip, et al.
Publicado: (2015)

Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients
por: Md Sakib Hossain, Dewan, et al.
Publicado: (2014)

Complementary cooperation of an ambulance helicopter and car with medical doctors: meaning of simultaneous dispatch
por: Ishii, K, et al.
Publicado: (2014)

Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy
por: Rushworth, David, et al.
Publicado: (2013)

Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer
por: Lynn, Rachel C, et al.
Publicado: (2015)

PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population
por: Qiu, Li-Xin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_begaevmampgc3qjdj590dmu8p2